Lung Cancer Screening, Version 3.2018 JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK Wood, D. E., Kazerooni, E. A., Baum, S. L., Eapen, G. A., Ettinger, D. S., Hou, L., Jackman, D. M., Klippenstein, D., Kumar, R., Lackner, R. P., Leard, L. E., Lennes, I. T., Leung, A. C., Makani, S. S., Massion, P. P., Mazzone, P., Merritt, R. E., Meyers, B. F., Midthun, D. E., Pipavath, S., Pratt, C., Reddy, C., Reid, M. E., Rotter, A. J., Sachs, P. B., Schabath, M. B., Schiebler, M. L., Tong, B. C., Travis, W. D., Wei, B., Yang, S. C., Gregory, K. M., Hughes, M. 2018; 16 (4): 412–41


Lung cancer is the leading cause of cancer-related mortality in the United States and worldwide. Early detection of lung cancer is an important opportunity for decreasing mortality. Data support using low-dose computed tomography (LDCT) of the chest to screen select patients who are at high risk for lung cancer. Lung screening is covered under the Affordable Care Act for individuals with high-risk factors. The Centers for Medicare & Medicaid Services (CMS) covers annual screening LDCT for appropriate Medicare beneficiaries at high risk for lung cancer if they also receive counseling and participate in shared decision-making before screening. The complete version of the NCCN Guidelines for Lung Cancer Screening provides recommendations for initial and subsequent LDCT screening and provides more detail about LDCT screening. This manuscript focuses on identifying patients at high risk for lung cancer who are candidates for LDCT of the chest and on evaluating initial screening findings.

View details for DOI 10.6004/jnccn.2018.0020

View details for Web of Science ID 000429534300011

View details for PubMedID 29632061